Welcome to the Integrated System for Pfizer Investigator Initiated Research (INSPIIRE)


For security, please type the letters above:
  New Users
Please email us at: CTD@pfizer.com for assistance with the CLINICAL TRIAL DATA REQUESTS
Please email us at: IIR@pfizer.com for assistance with INVESTIGATOR INITIATED RESEARCH or COMPOUND TRANSFER REQUESTS
ATTENTION HIV/Maraviroc Requests: Please contact viiv.csgoperations@viivhealthcare.com
Site is NOT compatible with Safari. Please use IE or Chrome when using this site.
NOTE: As of 03-Sept-2015, Pfizer has acquired Hospira. We will not accept any new proposals for legacy Hospira products until 01-Mar-2016.
If you are interested in submitting an avelumab proposal that includes another Merck Serono product, please submit directly via the Merck Serono portal.